Atlas Trials

Stage IV Laryngeal Cancer AJCC v8

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Laryngeal Cancer AJCC v8

RecordFirmDate
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (NCT05172258)National Cancer Institute (NCI)2022-07-26
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)National Cancer Institute (NCI)2022-07-06
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04862650)Marcelo Bonomi2021-11-30
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment (NCT04788264)Thomas Jefferson University2021-03-28
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin (NCT04541355)Hyunseok Kang, MD2020-10-14
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT04162873)University of Utah2019-11-27
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)M.D. Anderson Cancer Center2016-12-29

Track Stage IV Laryngeal Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.